NYSE:PHRHealthcare Services
Phreesia (PHR): Exploring Valuation Following Fresh 'Outperform' Rating and Analyst Optimism
Phreesia (PHR) just got a boost as BMO Capital initiated coverage with an 'Outperform' rating. This comes as other analysts continue to show optimism toward the company’s business and valuation prospects.
See our latest analysis for Phreesia.
After a stretch of analyst optimism, Phreesia’s share price has retreated, down 25% over the last 90 days. Yet patient investors have still enjoyed a strong 20.7% total shareholder return over the past year. While momentum has cooled recently, that...